St. Jude Medical Pacemakers & ICDs

Read Messages




Messages in Industry News Forum



Posted by kmcgrath on 2013-08-02 00:37. 1 comments. 686 reads
 
I'm a retired cyber security geek so this article hits home for me in a special way:

http://www.huffingtonpost.com/tom-patterson/pipelines-to-pacemakers_b_3671229.html

Posted by cathybuck on 2013-07-27 14:17. 5 comments. 1926 reads
 
Hello all, I'm a new member, I got my pacemaker almost 5 weeks ago after being diagnosed with sick sinus syndrome on top of AF. I've belonged to an afib group for awhile, and today someone posted this link to a story about a hacker who claimed he could reprogram pacemakers from 50 feet away.

Is this a joke? A real possibility? Or a wild exaggeration? I thought it was so cool that my St. Jude pacer had such extensive wireless capabilities but now I'm not so sure!

http://m.vice.com/en_au/read/i-worked-out-how-to-remotely-weaponise-a-pacemaker


Posted by admin on 2013-07-15 21:57. 1 comments. 570 reads
 
TYRX Receives FDA Clearance for Fully Resorbable AIGISRx® R Antibacterial Envelope

AIGISRx R Antibacterial Envelope Uniquely Designed to Combat Surgical Site Infections Associated with Cardiac Implantable Electronic Devices (CIEDs)

Monmouth Junction, NJ. (July 9, 2013): TYRX, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the Fully Resorbable AIGISRx R Antibacterial Envelope for use with pacemakers and implantable cardioverter defibrillators (ICDs). The AIGISRx R Antibacterial Envelope received approval from Health Canada in January 2013.

AIGISRx R is a fully bioresorbable, antibacterial mesh envelope, intended to hold CIEDs securely in place in ord...


Posted by admin on 2013-07-03 21:48. 1 comments. 689 reads
 
Athens, Greece (June 26, 2013): Use of TYRX, Inc.’s AIGISRx reduced major infection rates by 100% in patients undergoing Cardiovascular Implantable

Electronic Device (CIED) replacement procedures compared to case-matched retrospective control patients. Investigators presented new interim results from the Citadel / Centurion Clinical Study today at the Late Breaking Clinical Trials session at the European Heart Rhythm Association (EHRA), EUROPACE 2013.

The Citadel / Centurion study is a prospective, multicenter clinical study in patients at high-risk for CIED infection who have their CIED implanted with the AIGISRx Antibacterial Envelope. The aim of the study is to evaluate the impact of the AIGISRx Antibacterial E...


Posted by admin on 2013-05-25 07:54. 5 comments. 816 reads
 
Hello, attached below is a link to a short graduate research project by a student at the Medical University of South Carolina. The 5 question survey is in regards to pacemaker / defibrillator recall terminology. You may participate or choose not to participate in the survey. Thanks for your consideration!

Link: https://www.research.net/s/HQFR329


Posted by admin on 2013-05-15 21:20. 0 comments. 639 reads
 
Dr. Charles Henrikson, the Chief of Electrophysiology at the Oregon Health Sciences University, presented new prospective data on 1,000 patients showing 95% fewer major CIED infections in patients undergoing CIED replacement procedures using the AIGISRx Antibacterial Envelope compared to similar high-risk cohorts. These results were presented during the Late Breaking Clinical Trials session at Heart Rhythm 2013.

CITADEL / CENTURION is a prospective, multicenter clinical study to evaluate the major device infection and mechanical complication rates in the 12 months after implantation, in patients at high risk for CIED infection who have their CIED implanted with an AIGISRx Antibacterial Envelope. Study patients were enrolled at 5...


Posted by ma_ku on 2013-05-14 15:53. 0 comments. 602 reads
 
interesting read @ http://www.healio.com/cardiology/arrhythmia-disorders/news/online/%7B8E493D28-E94F-4FEC-AA00-CA09AF34E3BE%7D/Leadless-cardiac-pacemaker-safe-effective-in-first-in-man-study

Leadless and batteryless next I hope!

Posted by admin on 2013-04-17 21:05. 0 comments. 620 reads
 
Monmouth Junction, NJ. (April 15, 2013): TYRX, Inc., the leader in the commercialization of implantable medical devices intended to help reduce surgical site infections, announced today that the first implantation of its new AIGISRx R Fully Resorbable Antibacterial Envelope has taken place at the Quebec Heart and Lung Institute in Quebec City, Canada by Dr. François Philippon. TYRX announced on January 31, 2013 that it had received a license from Health Canada to market its AIGISRx R Fully Resorbable technology.

The AIGISRx R Antibacterial Envelope is specifically designed to stabilize Electronic Implantable Devices (EIDs), such as pacemakers and defibrillators, while also releasing antimicrobial agents to help provide protect...


Posted by pabrown on 2013-03-23 11:54. 2 comments. 1121 reads
 
Hello dear friends.
It's now gonna on 8 weeks since becoming 100% pacemaker dependent. I am still regaining my strength each day. I went back to my Dr for another check up and he said he would see me every 3 months. My pacemaker is one of the newest Boston's pm. advised me to continue to eat right and exercise and stay healthy. advised me to read this book Metabolic Cardiology written by Dr Stephen T Sinatra. well I have finished reading it and I was curious if any of you guys have tried or heard of any of the therapeutic intervention. Super nutrients coenzyme Q 10, L-carnitine and D-ribose. I realize that having this pacemaker,and the A V node ablation was the last resort but if there is any of you that have tried any of these su...


Posted by TraceyE on 2013-03-01 13:04. 6 comments. 1820 reads
 
from the Heart Rhythm Society
http://www.hrsonline.org/Practice-Guidance/Clinical-Guidelines-Documents/Featured-Guidelines-Folder/Appropriate-Use-Criteria-for-ICDs-and-CRT#axzz2MFWh7lXQ


Posted by Justinchu on 2013-02-25 01:33. 7 comments. 1495 reads
 
Hi everyone,

I just started to work with the company which made parts of elements in the pacemaker. And as I know there are some quiet famous companies like Guidant/ Medtronic/ St. Jude medical/ biotronik/ Sorin Group etc..
However, I wanna know if there are some famous pacemaker companies in France? I looked it up on the internet, but there seems no have much information about that.

Does anyone can kindly give me some answer? or how I should find the information?

I really appreciate that! Thank you all in advance!

Posted by agelbert on 2013-01-22 22:54. 0 comments. 567 reads
 
Surgeons at The Ohio State University Wexner Medical Center implanted the first brain pacemaker to treat Alzheimer’s last October, according to a university news release. Surgeons operated on Kathy Sanford, who became the first Alzheimer’s patient in the U.S. to have a pacemaker implanted in her brain.

Sanford is the first of as many as 10 patients who will be signed up for a study at Wexner Medical Center to decide if using a brain pacemaker can better cognitive and behavioral functioning in patients with Alzheimer’s disease.

Researchers hope to determine whether deep brain stimulation (DBS), the same technology used to successfully help approximately 100,000 patients worldwide with movement disorders such as Parkin...


Posted by agelbert on 2013-01-17 23:24. 1 comments. 814 reads
 
St. Vincent Heartbeat: New Device Aims to Repair Damaged Hearts

Doctors are testing a new device that may help repair damaged hearts by stimulating the vagus nerve.

When Mike Herasimuk had a massive heart attack two years ago, life as he knew it was over. He couldn't work, and could barely get around. He has heart failure.

"My heart's in really bad shape, that's why they were thinking of doing a heart transplant also, but I'm not quite bad enough," he says.

He has a pacemaker defibrillator to keep his heart beating.

Last month, Metrohealth doctors implanted an experimental device into his chest that may not only keep his heart beating, but may also improve it.

"It prevents...


Posted by agelbert on 2013-01-17 13:41. 5 comments. 2608 reads
 
they are implanting the new leadless pacemakers now. It appears that they are catheter positioned so the time to implant is reduced, no surgery takes place so the infection risk is limited to the catheter equipment (it happens sometimes-unfortunately) and the price of getting one will drop so more people who need on can get one. GOOD!

Patients fitted with first wireless pacemakers

16 January 2013

Prague, Jan 15 (CTK) - Czech patients have been the first in the world to benefit from the new leadless type of artificial cardiac pacemaker, Petr Neuzil, leading cardiologist in Prague's Na Homolce hospital who accomplished the first surgeries, told journalists yesterday.

The new device, designed to s...


Posted by admin on 2012-12-24 09:25. 0 comments. 602 reads
 
Vanderbilt Study Shows Sharp Decline in Cardiac Device Infections with TYRX® AIGISRx® Antibacterial Envelope

Results Demonstrate 87% Reduction in Infection Rate

Monmouth Junction, NJ (December 18, 2012): Patients at high risk for surgical site infection following Cardiac Implantable Electronic Device (CIED) implantation with TYRX, Inc.’s AIGISRx Antibacterial Envelope experienced significantly reduced risk of device infection compared to patients implanted without AIGISRx. Results of a retrospective cohort study of CIED implantations, including pacemakers and implantable defibrillators, were published online in the journal of Pacing and Clinical Electrophysiology (PACE).

Matthew J....


Posted by HeartOfBrick on 2012-11-05 12:07. 5 comments. 769 reads
 
Hi All,

I read this article and thought some would find it interesting:

New Device Could Allow Your Heartbeat to Power Pacemaker

ScienceDaily (Nov. 4, 2012) — An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012.

The findings suggest that patients could power their pacemakers -- eliminating the need for replacements when batteries are spent.

In a preliminary study, researchers tested an energy-harvesting device that uses piezoelectricity -- electrical charge generated from motion. The approach is a promising technological solution for pacemakers...


Posted by admin on 2012-10-11 21:27. 4 comments. 990 reads
 

Medicare Ruling Concerns Hospital CEOs, but Better Reporting, New Antibiotic Technology Can Lower Cardiac Device Infection Rates

Majority of CEOs Believe They Can Influence Hospital Practices to Reduce CIED Infections, Cost

Monmouth Junction, NJ (October 11, 2012): A new Medicare ruling that makes potentially avoidable surgical site infections (SSIs) following cardiac implantable electronic device (CIED)
procedures non-reimbursable could have significant financial and quality rating impacts for hospitals, according to a new survey of hospital chief executive officers (CEOs). At the same
time, a majority of the CEOs surveyed believed they could influence their electrophysiology/catheterization ...



Posted by admin on 2012-09-25 21:12. 3 comments. 1165 reads
 
For many, biggest barrier to pacemakers is cost

* No devices approved by the FDA for reuse

* Two manufacturers oppose reuse or reprocessing

By Andrew M. Seaman
www.reuters.com

NEW YORK, Sept 13 (Reuters Health) - Some pacemakers removed during hospital autopsies have enough battery life left in them to be reused in people with heart problems in developing countries, a new study says.

Researchers found that of 334 autopsies performed at the University of Pennsylvania between February 2009 and July 2011, 27 pacemakers and implantable cardioverter-defibrillators (ICDs) were recovered.

Of those, eight devices had at least four years of battery life remaining.

"Th...


Posted by admin on 2012-09-16 21:58. 4 comments. 1514 reads
 
AIGISRx Antibacterial Envelope for Pacemakers and Defibrillators Recognized by Frost & Sullivan

Monmouth Junction, NJ (September 14, 2012) – TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections associated with cardiovascular implantable electronic devices (CIEDs) including pacemakers and implantable defibrillators, announced today that Frost & Sullivan has named the AIGISRx Antibacterial Envelope as the recipient of its prestigious New Product Innovation Award for 2012.

“To date TYRX’s AIGISRx is very unique in the fact that it is the first and only antibacterial product of its kind to receive U.S. Food and Drug Administration (FDA) clearance. ...


Posted by admin on 2012-08-21 21:56. 8 comments. 1250 reads
 
Over 50% of Hospital CFOs Plan to Adopt New Technology in Response to Medicare Cuts for Cardiac Device Infections

-- National Survey Shows that Cardiac Device Infections Will Have a Significant Financial Impact NowThat Medicare Will No Longer Reimburse --

Monmouth Junction, NJ (August 20, 2012): Medicare’s decision to stop reimbursing hospitals for the treatment of potentially avoidable surgical site infections following cardiac implantable electronic device (CIED) procedures, including pacemaker and defibrillator implants, will significantly impact hospital practices according to a new national survey of hospital chief financial officers (CFOs).

The Centers for Medicare and Medicaid Services (CMS) recently...




Member Login
email:

password:



Who's Online?
We have 178 visitors online.

Members online:
  Wpw64

Polls
What type of device do you have?

Single lead pacer
Dual lead pacer
CRT
CRT-D
ICD

You're Wired When...
You play MP3 files on your pacer.

Member Quotes
A pacemaker completely solved my problem. In fact, it was implanted just 7 weeks ago and I ran a race today, placed first in my age group.

Seatbelt Comfort for Pacemaker Patients



Site content and design © 2000-2015 Pacemaker Club Inc.
All rights reserved.